Log In Sign up
The largest database of trusted experimental protocols
> Procedures > Therapeutic or Preventive Procedure > Biphasic Continuous Positive Airway Pressure

Biphasic Continuous Positive Airway Pressure

Biphasic Continuous Positive Airway Pressure (Biphasic CPAP) is a type of respiratory support that provides two levels of positive airway pressure during the breathing cycle.
This technique aims to improve oxygenation and ventilation in patients with respiratory distress or failure.
Biphasic CPAP involves alternating between a higher pressure during inspiration and a lower pressure during expiration, potentially reducing the work of breathing and enhancing patient comfort.
This approach has been studied in various clinical settings, including neonatal, pediatric, and adult populations, with the goal of optimizing patient outcomes and advancing respiratory care research.

Most cited protocols related to «Biphasic Continuous Positive Airway Pressure»

1
Aerosol Exposure Risk for Healthcare Workers
Cited 21 times
Eligible studies included health technology assessments (HTAs), systematic reviews, meta-analyses, randomized controlled trials, and non-randomized studies. The study population involved HCWs caring for patients with acute respiratory infections. The intervention was the provision of care to patients undergoing aerosol generating procedures (exposed to the procedures). The comparator was the provision of care to patients not undergoing aerosol generating procedures (unexposed to the procedures). The outcome of interest was the risk of transmission of acute respiratory infections from patients to HCWs. Procedures that might promote the generation of droplets or aerosols (non-exhaustive list) included non-invasive ventilation (CPAP and BiPAP), endotracheal intubation, airway suctioning, high frequency oscillatory ventilation, bag-valve mask ventilation, chest physiotherapy, nebulizer therapies, aerosol humidification, bronchoscopy or other upper airway endoscopy, tracheotomy, and open thoracotomy.
Tran K., Cimon K., Severn M., Pessoa-Silva C.L, & Conly J. (2012). Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLoS ONE, 7(4), e35797.
Full text: Click here
Publication 2012
Biphasic Continuous Positive Airway Pressure Bronchoscopy Chest Continuous Positive Airway Pressure Endoscopy High-Frequency Oscillation Ventilation Intubation, Intratracheal Nebulizers Noninvasive Ventilation Patients Respiratory Tract Infections Technology Assessment, Biomedical Therapy, Physical Thoracotomy Tracheotomy Transmission, Communicable Disease
2
Systematic Review and Meta-analysis of COVID-19 Treatments
Cited 8 times
For each eligible trial, pairs of reviewers, following training and calibration exercises, extracted data independently using a standardised, pilot tested data extraction form. Reviewers collected information on trial characteristics (trial registration, publication status, study status, design), patient characteristics (country, age, sex, smoking habits, comorbidities, setting and type of care, and severity of covid-19 symptoms for studies of treatment), and outcomes of interest (means or medians and measures of variability for continuous outcomes and the number of participants analysed and the number of participants who experienced an event for dichotomous outcomes). Reviewers resolved discrepancies by discussion and, when necessary, with adjudication by a third party. We updated the data collected from included preprints as soon as the peer review publication became available.
Outcomes of interest were selected based on importance to patients18 (link) and were informed by clinical expertise in the systematic review team and in the linked guideline panel responsible for the WHO-BMJ Rapid Recommendations.19 (link)
7 (link)
8 (link) The panel includes unconflicted clinical and methodology experts, recruited to ensure global representation, and patient partners. All panel members rated outcomes from 1 to 9 based on importance to individual patients (9 being most important), and we included any outcome rated 7 or higher by any panel member. Selected outcomes included mortality (closest to 90 days), mechanical ventilation (total number of patients, over 90 days), adverse events leading to discontinuation (within 28 days), admission to hospital, length of hospital stay, duration of mechanical ventilation, and time to symptom resolution or clinical improvement. In contrast to previous iterations, for this iteration, we did not include several outcomes which the GDG did not think were critical to decision making: viral clearance (closest to 7 days, 3 days either way), time to viral clearance, intensive care unit (ICU) length of stay, and days free from mechanical ventilation (within 28 days).
Mechanical ventilation includes both invasive and non-invasive mechanical ventilation. We used a hierarchy for the outcome mechanical ventilation in which we preferentially used the total number of patients who received mechanical ventilation over the study. We used the number of patients ventilated at the time point that the largest number of the patients were ventilated, if the trial reported the number of patients ventilated at specific timepoints. We used author definitions for mechanical ventilation; when separate, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) were considered non-invasive mechanical ventilation.
Siemieniuk R.A., Bartoszko J.J., Zeraatkar D., Kum E., Qasim A., Díaz Martinez J.P., Izcovich A., Rochwerg B., Lamontagne F., Han M.A., Agarwal A., Agoritsas T., Azab M., Bravo G., Chu D.K., Couban R., Cusano E., Devji T., Escamilla Z., Foroutan F., Gao Y., Ge L., Ghadimi M., Heels-Ansdell D., Honarmand K., Hou L., Ibrahim S., Khamis A., Lam B., Mansilla C., Loeb M., Miroshnychenko A., Marcucci M., McLeod S.L., Motaghi S., Murthy S., Mustafa R.A., Pardo-Hernandez H., Rada G., Rizwan Y., Saadat P., Switzer C., Thabane L., Tomlinson G., Vandvik P.O., Vernooij R.W., Viteri-García A., Wang Y., Yao L., Zhao Y., Guyatt G.H, & Brignardello-Petersen R. (2020). Drug treatments for covid-19: living systematic review and network meta-analysis. The BMJ, 370, m2980.
Publication 2020
Biphasic Continuous Positive Airway Pressure Continuous Positive Airway Pressure COVID 19 Mechanical Ventilation Noninvasive Ventilation Patients Peer Review
3
PARDIE: Pediatric Acute Respiratory Distress International Study
Cited 7 times

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Arteries Biphasic Continuous Positive Airway Pressure Blood Cardiopulmonary Bypass Cell Respiration Chest Child Continuous Positive Airway Pressure Cyanosis Diagnosis Ethics Committees, Research Heart Heart Diseases Heart Failure Hispanic or Latino Lung Diseases Mechanical Ventilation Noninvasive Ventilation Nose Oxygen Saturation Patient Discharge Patients Pharmaceutical Preparations Pulse Rate Radiologist Respiratory Failure Saturation of Peripheral Oxygen
4
Osteoporotic Fractures in Men Study
Cited 7 times
During the Osteoporotic Fractures in Men Study (MrOS) baseline examination from 2000 to 2002, 5,994 community-dwelling men 65 years or older were enrolled at 6 clinical centers in the United States: Birmingham, Alabama; Minneapolis, Minnesota; Palo Alto, California; the Monongahela Valley near Pittsburgh, Pennsylvania; Portland, Oregon; and San Diego, California.33 (link),34 (link) In order to participate, men needed to be able to walk without assistance and must not have had a bilateral hip replacement.
The MrOS Sleep Study, an ancillary study of the parent MrOS cohort, was conducted between December 2003 and March 2005 and recruited 3,135 of these participants (exceeding the goal of 3,000 participants) for a comprehensive sleep assessment. Men were screened for nightly use of mechanical devices during sleep including pressure mask for sleep apnea [CPAP or bilevel positive airway pressure (BiPAP)], mouthpiece for snoring or sleep apnea, or oxygen therapy and were generally excluded. Of the 2,859 men who did not participant in this ancillary study, 344 died before the sleep visit, 36 had already terminated the study, 332 were not asked because recruitment goals had already been met, 150 were not eligible, and 1,997 refused. Cognitive function data was available for 3,132 men. Of these, 2,909 had in-home overnight polysomnography (PSG) recordings and comprise our analytic cohort. All men with PSG data had information on SDB and nocturnal hypoxemia. Of the 2,909 PSG recordings, 39 had no data available on sleep architecture.
All men provided written informed consent, and the study was approved by the Institutional Review Board at each site.
Blackwell T., Yaffe K., Ancoli-Israel S., Redline S., Ensrud K.E., Stefanick M.L., Laffan A, & Stone K.L. (2011). Associations of Sleep Architecture and Sleep Disordered Breathing with Cognition in Older Community-Dwelling Men: The MrOS Sleep Study. Journal of the American Geriatrics Society, 59(12), 2217-2225.
Publication 2011
Biphasic Continuous Positive Airway Pressure Cognition Continuous Positive Airway Pressure Ethics Committees, Research Fracture, Bone Medical Devices Melkersson-Rosenthal Syndrome Multiple Endocrine Neoplasia Type 2b Parent Polysomnography Pressure Replacement Arthroplasties, Hip Sleep Sleep Apnea Syndromes Therapies, Oxygen Inhalation
5
COVID-19 Severity Antibody Profiling
Cited 6 times
We enrolled 987 patients with proven life-threatening (critical) COVID-19, 663 asymptomatic or pauci-symptomatic individuals with proven COVID-19, and 1227 healthy controls in this study. All subjects were recruited following protocols approved by local Institutional Review Boards (IRBs). All protocols followed local ethics recommendations and informed consent was obtained when required.
COVID-19 disease severity was assessed in accordance with the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia. The term life-threatening COVID-19 pneumonia describes pneumonia in patients with critical disease, whether pulmonary, with mechanical ventilation [continuous positive airway pressure (CPAP), bilevel positive airway pressure (BIPAP), intubation, or high-flow oxygen], septic shock, or damage to any other organ requiring admission in the intensive care unit (ICU). The individuals with asymptomatic or mild SARS-CoV-2 infection were individuals infected with SARS-CoV-2 who remained asymptomatic or developed mild, self-healing, ambulatory disease with no evidence of pneumonia. The healthy controls were individuals who had not been exposed to SARS-CoV-2.
Plasma and serum samples from the patients and controls were frozen at −20°C immediately after collection. The fluid-phase LIPS assay was used to determine the levels of antibodies against the SARS-CoV-2 nucleoprotein and spike protein, as has been previously described (31 (link)).
Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham K., Philippot Q., Rosain J., Béziat V., Manry J., Shaw E., Haljasmägi L., Peterson P., Lorenzo L., Bizien L., Trouillet-Assant S., Dobbs K., de Jesus A.A., Belot A., Kallaste A., Catherinot E., Tandjaoui-Lambiotte Y., Le Pen J., Kerner G., Bigio B., Seeleuthner Y., Yang R., Bolze A., Spaan A.N., Delmonte O.M., Abers M.S., Aiuti A., Casari G., Lampasona V., Piemonti L., Ciceri F., Bilguvar K., Lifton R.P., Vasse M., Smadja D.M., Migaud M., Hadjadj J., Terrier B., Duffy D., Quintana-Murci L., van de Beek D., Roussel L., Vinh D.C., Tangye S.G., Haerynck F., Dalmau D., Martinez-Picado J., Brodin P., Nussenzweig M.C., Boisson-Dupuis S., Rodríguez-Gallego C., Vogt G., Mogensen T.H., Oler A.J., Gu J., Burbelo P.D., Cohen J.I., Biondi A., Bettini L.R., D'Angio M., Bonfanti P., Rossignol P., Mayaux J., Rieux-Laucat F., Husebye E.S., Fusco F., Ursini M.V., Imberti L., Sottini A., Paghera S., Quiros-Roldan E., Rossi C., Castagnoli R., Montagna D., Licari A., Marseglia G.L., Duval X., Ghosn J., Tsang J.S., Goldbach-Mansky R., Kisand K., Lionakis M.S., Puel A., Zhang S.Y., Holland S.M., Gorochov G., Jouanguy E., Rice C.M., Cobat A., Notarangelo L.D., Abel L., Su H.C, & Casanova J.L. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (New York, N.y.), 370(6515), eabd4585.
Full text: Click here
Publication 2020
Antibodies Biological Assay Biphasic Continuous Positive Airway Pressure Continuous Positive Airway Pressure COVID 19 Diagnosis Ethics Committees, Research Freezing Intubation Lip Lung Lung Diseases Mechanical Ventilation M protein, multiple myeloma nucleocapsid phosphoprotein, SARS-CoV-2 Oxygen Patients Plasma Pneumonia SARS-CoV-2 Septic Shock Serum Treatment Protocols

Most recents protocols related to «Biphasic Continuous Positive Airway Pressure»

1
COVID-19 Lipid Profile and Severity

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Aged Biphasic Continuous Positive Airway Pressure Continuous Positive Airway Pressure COVID 19 Diagnosis Ethics Committees, Research Extracorporeal Membrane Oxygenation Genes Hospitalization Infection Intubation Lipid A Mechanical Ventilation Noninvasive Ventilation Nose Oxygen Patients Primary Health Care Real-Time Polymerase Chain Reaction Residency Reverse Transcriptase Polymerase Chain Reaction SARS-CoV-2 SERPINA3 protein, human Therapies, Oxygen Inhalation Vasoconstrictor Agents
2
Genetic Susceptibility and COVID-19 Severity
An observational analytic study with a case-control design was conducted at outpatient clinics and inpatient wards in the clinical settings of Poltava State Medical University, Ukraine, from August 2020 through February 2021. Written informed consent was obtained from all recruited patients. The study was approved by the local Ethics Committee of Poltava State Medical University, Ukraine.
The study population consisted of Ukrainian COVID-19 patients who had resided in the Poltava region (central part of Ukraine). The inclusion criteria for the study group were subjects with clinical signs and symptoms of COVID-19: i) endotracheal intubation, ii) CPAP/BiPAP ventilation, iii) oxygen therapy, iv) hospitalized without oxygen therapy, v) not hospitalized, and positive results of SARS-CoV-2 PCR tests in nasopharyngeal swabs (14 (link)).
All COVID-19 patients were divided into three clinical groups in accordance with oxygen requirement: group 1 – patients without oxygen therapy (n=62), group 2 – patients with non-invasive oxygen therapy (n=92), group 3 – patients with lung ventilation (invasive oxygen therapy) including 8 patients who died (n=35). We allocated such groups in order to be able to compare our data with previously published results on the gene polymorphisms associations with COVID-19 severity. The control group comprised 92 healthy persons, without a history of fever or respiratory symptoms who had a negative SARS-CoV-2 IgA+IgM+IgG serology and lived in Central Ukraine.
Izmailova O., Shlykova O., Kabaliei A., Vatsenko A., Ivashchenko D., Dudchenko M., Volianskyi A., Zelinskyy G., Koval T., Dittmer U, & Kaidashev I. (2023). Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population. Acta Bio Medica : Atenei Parmensis, 94(1), e2023030.
Publication 2023
Biphasic Continuous Positive Airway Pressure Continuous Positive Airway Pressure COVID 19 Fever Genetic Polymorphism Group Therapy Inpatient Intubation, Intratracheal Nasopharynx Oxygen Patients Regional Ethics Committees SARS-CoV-2 Signs and Symptoms, Respiratory Therapies, Oxygen Inhalation
3
Thromboembolism and Bleeding Outcomes

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Arteries Biphasic Continuous Positive Airway Pressure Cardiovascular System Continuous Positive Airway Pressure Deep Vein Thrombosis Inotropism Intubation, Intratracheal Mechanical Ventilation Myocardial Infarction Nasal Cannula Operative Surgical Procedures Oxygen Patients Pulmonary Embolism Respiratory Rate Safety Stroke, Ischemic Thromboembolism Vasoconstrictor Agents Venous Thromboembolism
4
COPD Patients with Sleep Apnea: Evaluation
Consecutive COPD patients, referred to the Sleep Unit of our Department for evaluation of sleep disordered breathing from November 2017 to June 2020 and diagnosed with OSA (Αpnea hypopnea index, AHI ≥ 5/h), were prospectively enrolled in the study. Eligible patients were aged 40 years or older; were current or ex‐smokers with at least 10 pack‐year smoking history; had a diagnosis of stable COPD in the last month and received optimal bronchodilation treatment before the sleep study as per guidelines8; were able to understand and complete the study related procedures.
The following exclusion criteria were applied: central sleep apnea syndrome; recent infection and/or exacerbation history in the previous 3 months; respiratory acidosis or severe hypercapnia in wakefulness (pCO2 > 55 mmHg) in need for admission and ventilatory support with Bilevel Positive Airway Pressure; coexistent asthma; oral corticosteroid and immunomodulatory medications; active cancer; unstable cardiovascular disease (CVD) and any unstable concurrent disease; and/or clinically significant laboratory abnormalities.
Voulgaris A., Archontogeorgis K., Anevlavis S., Fanaridis M., Froudarakis M.E., Schiza S, & Steiropoulos P. (2023). Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome). The Clinical Respiratory Journal, 17(3), 165-175.
Full text: Click here
Publication 2023
Acidosis, Respiratory Adrenal Cortex Hormones Asthma Biphasic Continuous Positive Airway Pressure Cardiovascular Diseases Chronic Obstructive Airway Disease Congenital Abnormality Diagnosis Ex-Smokers Immunomodulation Infection Malignant Neoplasms Patients Pharmaceutical Preparations Polysomnography Sleep Sleep Apnea, Central Wakefulness
5
Severe Acute Asthma in PICU: Observational Study
We performed a single-center, prospective, observational cohort study of children between the ages of 6–17 years who were admitted to the Emory University-affiliated Children’s Healthcare of Atlanta 36-bed PICU for severe acute asthma between July 29, 2019, and February 10, 2021. The Emory University School of Medicine Institutional Review Board (IRB00110747) approved the study. Informed consent was obtained from all participants and/or their parent or legal guardian prior to enrollment. In accord with institutional requirements, we obtained verbal assent from children 6–10 years and written assent from children 11 years of age or greater prior to enrollment and any study procedures. All study procedures were performed according to the relevant guidelines and regulations in the Declaration of Helsinki. Children are admitted to the PICU for asthma if they received any of the following interventions in the Emergency Department: (1) a third continuous nebulized albuterol treatment, (2) non-invasive respiratory support delivered by high-flow nasal cannula or bilevel positive airway pressure, (3) intubation for invasive mechanical ventilation, (4) receipt of a 80%/20% helium–oxygen mixture for hypoxemia, or (5) required greater than or equal to 50% fraction of inspired oxygen by Venturi mask or positive pressure ventilation to maintain oxygen saturations ≥ 92%. Children were excluded if they had other chronic medical conditions requiring systemic corticosteroids or had disorders necessitating immunosuppressive medications such as a history of hematopoietic stem cell or solid organ transplant, oncologic diagnoses, sickle cell anemia, or rheumatologic diagnoses. Children with respiratory comorbidities such as cystic fibrosis, pulmonary aspiration, gastroesophageal reflux requiring acid suppression medication and/or tube-feed dependence, bronchiectasis, congenital airway anomalies, bronchopulmonary dysplasia, and/or a history of premature birth before 35-week gestation were excluded. Pregnant patients and those with a personal history of any recreational smoking or vaping were also excluded.
Cottrill K.A., Rad M.G., Ripple M.J., Stephenson S.T., Mohammad A.F., Tidwell M., Kamaleswaran R., Fitzpatrick A.M, & Grunwell J.R. (2023). Cluster analysis of plasma cytokines identifies two unique endotypes of children with asthma in the pediatric intensive care unit. Scientific Reports, 13, 3521.
Full text: Click here
Publication 2023
Adrenal Cortex Hormones Albuterol Anemia, Sickle Cell Asthma Biphasic Continuous Positive Airway Pressure Bronchiectasis Bronchopulmonary Dysplasia Child Children's Health Chronic Condition Congenital Abnormality Cystic Fibrosis Diagnosis Ethics Committees, Research Gastroesophageal Reflux Disease Helium Immunosuppressive Agents Intermittent Positive-Pressure Ventilation Intubation Legal Guardians Lung Mechanical Ventilation Nasal Cannula Neoplasms Organ Transplantation Oxygen Oxygen-20 Oxygen Saturation Parent Patients Pharmaceutical Preparations Pregnancy Premature Birth Respiratory Rate Status Asthmaticus Stem Cells, Hematopoietic

Top products related to «Biphasic Continuous Positive Airway Pressure»

1
Bipap vision by Philips
Sourced in United States
The BiPAP Vision is a non-invasive ventilator designed for patients with respiratory insufficiency. It provides two levels of positive airway pressure to assist breathing. The device is capable of delivering both inspiratory and expiratory positive airway pressure.
2
Bipap a40 by Philips
Sourced in United States
The BiPAP A40 is a non-invasive ventilation device designed to provide respiratory support. It delivers positive airway pressure to assist with breathing. The device is intended for use in a medical or home setting, as prescribed by a healthcare professional.
3
Bipap synchrony by Philips
Sourced in United States
The BiPAP Synchrony is a bi-level positive airway pressure (BiPAP) device designed to provide non-invasive ventilatory support. It delivers adjustable levels of inspiratory and expiratory positive airway pressure to assist with breathing. The device is intended for use in a hospital or clinical setting by healthcare professionals.
4
Respironics v60 by Philips
Sourced in Sweden
The Respironics V60 is a ventilator designed to assist with respiratory support. It provides noninvasive ventilation and can be used for a variety of patient populations. The device offers adjustable settings to meet the needs of the patient.
5
Encoreanywhere by Philips
Sourced in United States
EncoreAnywhere is a compact and versatile laboratory equipment designed for various analytical applications. It provides reliable and accurate measurements for researchers and scientists. The core function of EncoreAnywhere is to perform analytical tasks, but a detailed description without interpretation or extrapolation cannot be provided within the given constraints.
6
Airvo 2 by Fisher & Paykel Healthcare
Sourced in New Zealand
The Airvo 2 is a heated humidifier that delivers warm, humidified respiratory gases to patients who require respiratory support. It is designed to provide high-flow nasal therapy, which helps to improve patient comfort and respiratory function.
7
Directview by Philips
Sourced in United States, Sweden
DirectView is a line of laboratory equipment manufactured by Philips. It is designed to provide high-quality imaging and visualization capabilities for scientific and medical applications. The core function of DirectView is to capture, process, and display images and data from various analytical instruments and sensors.
8
Auto set cs by Resmed
Sourced in Australia
The AutoSet CS is a continuous positive airway pressure (CPAP) device designed to provide respiratory support for patients with sleep-disordered breathing, such as obstructive sleep apnea. The device automatically adjusts the air pressure delivered to the patient based on their breathing patterns, providing the optimal level of pressure required to maintain an open airway throughout the night.
9
Auto trak by Philips
Sourced in United States
The Auto-Trak is a laboratory equipment product designed for automated tracking and positioning of samples. It provides precise and consistent sample handling to support various laboratory applications.
10
Mirage 4 by Resmed
Sourced in United States
The Mirage IV is a lab equipment product manufactured by Resmed. It is designed to perform specific functions within a laboratory setting, but a detailed description of its core function cannot be provided while maintaining an unbiased and factual approach without extrapolation. As a marketing specialist, I do not have access to the technical specifications or intended use of this product, and I cannot generate a description that meets the criteria you have specified.

More about "Biphasic Continuous Positive Airway Pressure"

Biphasic Continuous Positive Airway Pressure (Biphasic CPAP) is a type of respiratory support that provides two levels of positive airway pressure during the breathing cycle.
This technique, also known as BiPAP or Bilevel CPAP, aims to improve oxygenation and ventilation in patients with respiratory distress or failure.
Biphasic CPAP involves alternating between a higher pressure during inspiration and a lower pressure during expiration, potentially reducing the work of breathing and enhancing patient comfort.
This approach has been studied in various clinical settings, including neonatal, pediatric, and adult populations, with the goal of optimizing patient outcomes and advancing respiratory care research.
The Biphasic CPAP technology has been incorporated into various respiratory devices, such as the BiPAP Vision, BiPAP A40, BiPAP Synchrony, Respironics V60, and EncoreAnywhere.
These devices may also feature additional functionalities like Auto-Trak, Airvo 2, DirectView, and Auto Set CS to further enhance the effectiveness and user-friendliness of Biphasic CPAP therapy.
By utilizing the insights gained from the MeSH term description and metadescription, researchers can optimize their Biphasic CPAP research with the help of tools like PubCompare.ai.
This AI-driven platform can assist in locating the best protocols from literature, pre-prints, and patents, thereby enhancing the reproducibility and accuracy of studies.
Discovering the most effective Biphasic CPAP methods and products can ultimately advance respiratory care research and improve patient outcomes.